A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson’s disease
Top Cited Papers
Open Access
- 17 January 2025
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (3) , eado4927
Abstract
Deep brain stimulation technology enables the neural modulation with precise spatial control but requires permanent implantation of conduits. Here, we describe a photothermal wireless deep brain stimulation nanosystem capable of eliminating α-synuclein aggregates and restoring degenerated dopamine neurons in the substantia nigra to treat Parkinson’s disease. This nanosystem (ATB NPs) consists of gold nanoshell, an antibody against the heat-sensitive transient receptor potential vanilloid family member 1 (TRPV1), and β-synuclein (β-syn) peptides with a near infrared–responsive linker. ATB NPs by stereotactic injection target dopamine neurons expressing TRPV1 receptors in the substantia nigra. Upon pulsed near-infrared irradiation, ATB NPs, serving as nanoantennae, convert the light into heat, leading to calcium ion influx, depolarization, and action potentials in dopamine neurons through TRPV1 receptors. Simultaneously, β-synuclein peptides released from ATB NPs cooperate with chaperone-mediated autophagy initiated by heat shock protein, HSC70, to effectively eliminate α-synuclein fibrils in neurons. These orchestrated actions restored pathological dopamine neurons and locomotor behaviors of Parkinson’s disease.Keywords
This publication has 71 references indexed in Scilit:
- Hot flash: TRPV channels in the brainTrends in Neurosciences, 2009
- Primary support cultures of hippocampal and substantia nigra neuronsNature Protocols, 2008
- Interactions between Hsp70 and the Hydrophobic Core of α-Synuclein Inhibit Fibril AssemblyBiochemistry, 2008
- Assembly-dependent endocytosis and clearance of extracellular a-synucleinThe International Journal of Biochemistry & Cell Biology, 2008
- The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-conceptNature Reviews Drug Discovery, 2007
- Millisecond-timescale, genetically targeted optical control of neural activityNature Neuroscience, 2005
- α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson diseaseNature Neuroscience, 2005
- A possible role for π‐stacking in the self‐assembly of amyloid fibrilsThe FASEB Journal, 2002
- Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and humanProceedings of the National Academy of Sciences, 2000
- Thermodynamics of protein association reactions: forces contributing to stabilityBiochemistry, 1981